Women in Bio: OMass Taps Biogen Vet Nathalie Franchimont for Board of Directors

Published

August 18, 2020

Women in Bio: OMass Taps Biogen Vet Nathalie Franchimont for Board of Directors

When U.K.-based OMass Therapeutics began the search for a new member for its board of directors, Chief Executive Officer Rosamond Deegan knew exactly what to do. She turned to a network of colleagues she developed through her past participation in the Executive Women In Bio Boardroom Ready Program…

MORERelated News
Ros Deegan: Always up for a new challenge: How Ros carved out a path to lead her own company
Always up for a new challenge, Ros describes the many twists and turns her career has taken over the years....
Lab crunch: British science has nowhere to go
OXFORD, England, June 20 (Reuters) - For Ros Deegan, the thrill of raising $100 million to expand a biotech firm...
Native mass spectrometry: Drug discovery’s new kid on the block
Current drug discovery methods have limited success against certain drug targets and better approaches are needed. Professor Dame Carol Robinson’s...